Compare REPL & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | REPL | PDLB |
|---|---|---|
| Founded | 2015 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.1M | 467.3M |
| IPO Year | 2018 | 2021 |
| Metric | REPL | PDLB |
|---|---|---|
| Price | $11.52 | $19.76 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $5.67 | N/A |
| AVG Volume (30 Days) | ★ 5.4M | 87.6K |
| Earning Date | 05-21-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 5.25 | ★ 160.87 |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $54.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $13.65 |
| 52 Week High | $13.24 | $19.78 |
| Indicator | REPL | PDLB |
|---|---|---|
| Relative Strength Index (RSI) | 76.15 | 65.99 |
| Support Level | $6.81 | $15.84 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.83 | 0.52 |
| MACD | 0.15 | 0.01 |
| Stochastic Oscillator | 82.66 | 97.37 |
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.